Home LiteratureArticle Details

PMID: 4139403 Published · ppublish English Clinical Trial Controlled Clinical Trial Journal Article

Intensive immunosuppression in the treatment of multiple sclerosis.

Lancet (London, England) ·Vol. 2 ·No. 7889 ·1974-11-09 ·Pages 1093-6

Ring J, Seifert J, Lob G, Coulin K, Angstwurm H, Frick E, Brass B, Mertin J, Backmund H, Brendel W

Abstract

暂无摘要

MeSH Terms

Adult Animals Antilymphocyte Serum/administration & dosage,therapeutic use Azathioprine/administration & dosage,therapeutic use Cells, Cultured Drainage Drug Therapy, Combination Follow-Up Studies Hemagglutination Tests Horses/immunology Humans Immune Tolerance Immunodiffusion Immunoglobulin G Immunosuppression Therapy Injections, Intravenous Lymphopenia/immunology Middle Aged Multiple Sclerosis/drug therapy,immunology,therapy Prednisolone/administration & dosage,therapeutic use Skin Tests Thoracic Duct gamma-Globulins/analysis

Chemicals

Antilymphocyte Serum Immunoglobulin G gamma-Globulins Prednisolone Azathioprine

Authors & Affiliations

10 authors, click to expand affiliations / ORCID

Ring J

Seifert J

Lob G

Coulin K

Angstwurm H

Frick E

Brass B

Mertin J

Backmund H

Brendel W

Article Info

Journal

Lancet (London, England)

Abbr.

Lancet

ISSN

0140-6736

DOI

10.1016/s0140-6736(74)90866-6

Published

1974-11-09

Pages

1093-6

Language

English

Region

England

NLM ID

2985213R

Subset

External Links

PubMed source DOI: 10.1016/s0140-6736(74)90866-6 View journal details

Analysis Services

Intensive immunosuppression in the treatment of multiple sclerosis.

Contact

WeChat Official Account